Amphastar Pharmaceuticals revenue was $240.18 m in FY, 2017
Amphastar Pharmaceuticals revenue breakdown by business segment: 5.9% from Active Pharmaceutical Ingredients and 94.1% from Finished pharmaceutical products
USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|
Revenue | 210.5m | 251.5m | 255.2m | 240.2m |
Revenue growth, % | 20% | 1% | ||
Cost of goods sold | 159.2m | 174.2m | 151.0m | 149.4m |
Gross profit | 51.3m | 77.3m | 104.2m | 90.8m |
Gross profit Margin, % | 24% | 31% | 41% | 38% |
Sales and marketing expense | 5.6m | |||
R&D expense | 28.4m | 37.1m | 41.2m | 43.4m |
General and administrative expense | 34.8m | 41.5m | 41.8m | 44.5m |
Operating expense total | 68.8m | 84.2m | 88.5m | 91.7m |
EBIT | (18.0m) | (6.9m) | 15.7m | (895.0k) |
EBIT margin, % | (9%) | (3%) | 6% | 0% |
Interest expense | 609.0k | 987.0k | 1.0m | 826.0k |
Interest income | 243.0k | 315.0k | 270.0k | 425.0k |
Pre tax profit | (18.1m) | (10.4m) | 14.9m | 1.6m |
Income tax expense | (7.4m) | (7.6m) | 4.4m | (2.9m) |
Net Income | (10.7m) | (2.8m) | 10.5m | 4.5m |
USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 49.0m | 59.7m | 56.9m | 53.9m | 63.9m | 59.4m | 68.0m | 64.2m | 56.7m | 65.2m | 57.9m | 58.4m | 71.0m | 75.5m |
Cost of goods sold | 34.0m | 47.9m | 43.6m | 40.5m | 46.3m | 34.5m | 36.3m | 36.6m | 33.8m | 38.4m | 37.3m | 41.3m | 44.9m | 46.3m |
Gross profit | 15.0m | 11.8m | 13.3m | 13.3m | 17.6m | 24.9m | 31.7m | 27.6m | 22.8m | 26.7m | 20.6m | 17.1m | 26.2m | 29.3m |
Gross profit Margin, % | 31% | 20% | 23% | 25% | 28% | 42% | 47% | 43% | 40% | 41% | 36% | 29% | 37% | 39% |
R&D expense | 6.0m | 8.6m | 6.6m | 10.7m | 11.1m | 8.4m | 10.5m | 9.7m | 11.3m | 10.7m | 10.0m | 14.3m | 15.5m | 11.3m |
General and administrative expense | 8.6m | 9.6m | 12.5m | 11.3m | 9.0m | 10.9m | 9.5m | 10.8m | 11.3m | 12.2m | 11.7m | 11.0m | 11.7m | 13.4m |
Operating expense total | 16.2m | 19.6m | 20.5m | 23.6m | 21.3m | 20.8m | 21.4m | 21.8m | 21.4m | 24.6m | 23.5m | 27.0m | 29.0m | 26.7m |
EBIT | (1.2m) | (7.8m) | (7.3m) | (10.3m) | (3.7m) | 4.1m | 10.3m | 5.8m | 1.4m | 2.2m | (2.8m) | (9.9m) | (2.9m) | 2.6m |
EBIT margin, % | (2%) | (13%) | (13%) | (19%) | (6%) | 7% | 15% | 9% | 2% | 3% | (5%) | (17%) | (4%) | 3% |
Interest expense | 476.0k | 504.0k | 341.0k | 210.0k | 232.0k | 384.0k | 305.0k | 281.0k | 191.0k | 237.0k | 264.0k | 18.0k | 100.0k | 124.0k |
Interest income | 32.0k | 94.0k | 92.0k | 65.0k | 83.0k | 74.0k | 50.0k | 63.0k | 91.0k | 87.0k | 124.0k | 124.0k | 106.0k | 105.0k |
Pre tax profit | (1.9m) | (8.0m) | (6.2m) | (10.2m) | (4.3m) | 3.8m | 9.8m | 6.0m | 1.5m | 3.2m | (2.0m) | (9.0m) | (4.1m) | 2.6m |
Income tax expense | (696.0k) | (2.6m) | (5.5m) | (3.6m) | (1.3m) | 1.3m | 2.9m | 2.1m | 611.0k | 1.2m | (2.2m) | (1.8m) | (1.3m) | 958.0k |
Net Income | (1.2m) | (5.4m) | (665.0k) | (6.6m) | (3.0m) | 2.5m | 6.9m | 3.9m | 893.0k | 2.0m | 175.0k | (7.2m) | (2.8m) | 1.6m |
usd | Y, 2012 | Y, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|---|
Cash | 50.2m | 53.6m | 67.8m | 66.1m | 72.4m | 65.6m |
Accounts Receivable | 22.9m | 33.2m | 26.8m | 36.0m | ||
Inventories | 118.4m | 63.6m | ||||
Current Assets | 198.0m | 175.9m | 184.1m | 187.8m | ||
PP&E | 138.3m | 142.2m | 152.9m | 185.3m | ||
Goodwill | 42.6m | 39.9m | 50.3m | 45.1m | ||
Total Assets | 389.4m | 390.1m | 427.7m | 454.7m | ||
Accounts Payable | 10.2m | 13.9m | 16.2m | 57.6m | ||
Current Liabilities | 62.6m | 60.0m | 60.6m | 67.2m | ||
Total Liabilities | 98.5m | 117.3m | ||||
Additional Paid-in Capital | 220.7m | 247.8m | 283.1m | 313.9m | ||
Retained Earnings | 63.1m | 60.3m | 70.9m | 76.2m | ||
Total Equity | 295.5m | 329.3m | 337.3m | |||
Financial Leverage | 1.3 x | 1.3 x | 1.3 x |
usd | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|
Net Income | (10.7m) | (2.8m) | 10.5m | 4.5m |
Depreciation and Amortization | 12.0m | 12.6m | ||
Accounts Receivable | 1.2m | 6.4m | (8.1m) | |
Inventories | 9.1m | (9.7m) | 18.7m | |
Accounts Payable | 7.0m | 6.7m | ||
Cash From Operating Activities | 14.2m | (1.8m) | 38.6m | 39.2m |
Purchases of PP&E | (18.7m) | |||
Cash From Investing Activities | (39.8m) | (39.5m) | (38.8m) | |
Long-term Borrowings | (8.2m) | (14.7m) | (9.7m) | |
Cash From Financing Activities | 32.1m | 7.1m | (7.7m) | |
Interest Paid | 2.6m | |||
Income Taxes Paid | 436.0k | 3.4m | 4.9m |
USD | Y, 2018 |
---|---|
Financial Leverage | 1.4 x |
FY, 2016 | |
---|---|
Facilities | 5 |
Products | 19 |